prostate
The prostate cancer androgen receptor cistrome in African American men associates with upregulation of lipid metabolism and immune response
African American (AA) men are more likely to be diagnosed with and die from prostate cancer (PCa) than European American (EA) men. Despite the cent...
Prostate cancer upgrading and adverse pathology in Hispanic men undergoing radical prostatectomy
Purpose:
Radical prostatectomy (RP) outcomes in Hispanic men with prostate cancer are not well-described. Prior studies showed varyi...
Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity
Purpose:
Stereotactic ablative radiotherapy (SABR) has demonstrated clinical benefit in oligometastatic prostate cancer. However, th...
African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show
NEW YORK – African American men with prostate cancer are receiving more limited germline genetic testing for cancer risk and getting more uncertain...
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017
…significant differences in long-term prostate cancer outcomes in Caucasian American compared to African American men. This study explored wh...
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017
Background:
There is substantial variability in prostate cancer (PCa) mortality rates across Caucasian American (CA), African Americ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
